However, recent discovery of lymphangiogenic factor, vascular endothelial growth factor-C (VEGF-C), and specific lymphatic markers (LYVE-1 and D2-40) now allow researchers to identify and focus on the role of lymphangiogenesis in tumor metastases and to determine whether they have prognostic implications. This evidence concerns the gene LYVE1 and neoplasm.